CRVS · Corvus Pharmaceuticals, Inc. · Proposed Sales
$10.44
-0.10 (-0.95%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$886.63M
Shares
84.12M
Volume · Oct 28
603.5K
Avg daily vol (3M)
996.23K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
21 filings
21 filers
Visit website
Investor relations